

Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine)
Manufactured By
Alkem
Pack Of
1
Salt Composition
Fosaprepitant Dimeglumine
Storage
Keep in cold place
Overview
Apriset I.V. 150mg Injection is a prescription antiemetic medication used in patients experiencing nausea and vomiting induced by chemotherapy. Its active salt composition is Fosaprepitant Dimeglumine, which is classified as a neurokinin-1 (NK1) receptor antagonist.
It works by blocking the action substance P, a chemical in the body that activates nausea and vomiting. The medication is not given to adults or children under the age of 18.
Quick Product Facts
| Field | Publication wording |
|---|---|
| Brand | apriset i v |
| Generic / Active Ingredient | Apriset I.V |
| Strength | 150 |
| Dosage Form | Injection |
| Manufacturer / Marketer | alkem |
| Pack Size | 1 |
| Prescription Required | Yes |
| Therapeutic Categories | Cancer Medicines |
| Uses | Chemotherapy |
Uses and Indications
Chemotherapy
Side Effects of Apriset I.V 150mg Injection
Some people may tolerate the infection but it can be manageable with the safety considerations and several treatment options. Consult the doctor if any of the symptoms persist or worsen while taking Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine):
● Headache
● Hiccup
● Indigestion
● Fatigue
● Decreased appetite
● Constipation
Apriset I.V 150mg Injection Dosage and How To Take It
Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine) should always be taken as recommended by a healthcare professional. Consume the tablet with food or without food at the same time every day to enhance the effectiveness of the treatment.
Do not overdose on the medicine to make up for the missed one, as this may cause severe side effects. Always consult the doctor before starting the treatment.
Safety Advice for Apriset I.V 150mg Injection
- ● Alcohol: Alcohol can worsen the side effects like low blood pressure and dizziness. Try to limit or avoid intake of alcohol while using Fosaprepitant I.V 150mg Injection (Apriset).
- ● Driving: Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine) may cause dizziness and drowsiness in some patients. Avoid driving if these symptoms persist, and consult your doctor promptly for dose adjustment or supportive care to ensure safe and effective treatment.
- ● Pregnancy: Apriset I.V 150mg Injection is not recommended to the pregnant women as it causes serious health issues to the unborn baby.
- ● Breastfeeding: Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine) use with caution or avoid during breastfeeding. Consult a doctor before use, as the medicine may pass into breast milk and could potentially harm the nursing infant.
- ● Kidney: Inform the doctor before taking Fosaprepitant I.V 150mg Injection (Apriset) as it may affect kidney functions.
- ● Liver: Apriset I.V 150mg Injection should be used with caution in patients with liver impairment, as it may affect liver function and could complicate the management of the condition.
FAQs About Apriset I.V 150mg Injection
1. Is heart patient use Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine)?
Yes, a heart patient may use the Apriset I.V 150mg injection, but only if it is prescribed by the doctor.
2. How long is Fosaprepitant I.V 150mg Injection (Apriset) used?
Apriset I.V 150mg Injection is used until the doctor advises to stop it. Do not self-administer the medication without consulting a doctor.
3. Can I use Apriset I.V 150mg Injection 1 day before the expiry date?
While taking the Apriset I.V 150mg injection one day before the expiry is unlikely to cause any harm, guidance from the doctor is required at the time of medication.
4. Who can use Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine)?
Apriset I.V 150mg Injection is used to prevent the patient from nausea and vomiting caused by the chemotherapy.
5. Are Fosaprepitant I.V 150mg Injection (Apriset) cause any side effects?
Apriset I.V 150mg Injection (Fosaprepitant Dimeglumine) causes certain side effects such as headache, fatigue, constipation, etc., but they are manageable with various treatments. Visit the doctor if any of the symptoms persist or worsen.
References
● Garnock-Jones, K. P. (2016). Fosaprepitant dimeglumine: a review in the prevention of nausea and vomiting associated with chemotherapy. Drugs, 76(14), 1365-1372.
● Colon-Gonzalez, F., & Kraft, W. K. (2010). Pharmacokinetic evaluation of fosaprepitant dimeglumine. Expert opinion on drug metabolism & toxicology, 6(10), 1277-1286.
● Van Belle, S. J., & Cocquyt, V. (2008). Fosaprepitant dimeglumine (MK-0517 or L-785,298), an intravenous neurokinin-1 antagonist for the prevention of chemotherapy induced nausea and vomiting. Expert Opinion on Pharmacotherapy, 9(18), 3261-3270.
● Candelario, N., & Lu, M. L. R. (2016). Fosaprepitant dimeglumine for the management of chemotherapy-induced nausea and vomiting: patient selection and perspectives. Cancer Management and Research, 77-82.
● Lu, K., Lin, S., Wang, Y., Hao, R., Fang, L., Zhu, J., ... & Wang, Y. (2021). Pharmacokinetics and safety of fosaprepitant dimeglumine in healthy chinese volunteers: bioequivalence study. Clinical Pharmacology in Drug Development, 10(7), 748-755.
Marketer Details
Alkem
Disclaimer
Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.


